Fatty liver disease

I have mixed feelings as summer begins to pack up shop for the year. This season has a certain energy, like a house party with…

My daughter has never asked much about my health, let alone how I live with metabolic dysfunction-associated steatohepatitis (MASH). I don’t expect her to…

Regulators in the European Union (EU) have granted conditional approval to Rezdiffra (resmetirom) for some people with metabolic dysfunction-associated steatohepatitis (MASH), making it the first…

The U.S. Food and Drug Administration (FDA) has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat certain people with metabolic dysfunction-associated steatohepatitis (MASH), a…

Having a chronic disease like my metabolic dysfunction-associated steatohepatitis (MASH) can play tricks on not just your body, but also your mind. Case in…

India’s Central Drugs Standard Control Organization has approved the oral therapy nor-ursodeoxycholic acid (NorUDCA) for people with metabolic dysfunction-associated steatotic liver disease (MASLD), a form…

Eating is one of my pleasures in life, especially when the food is good. However, my current diet is much healthier than it was when…

The proportion of cases of hepatocellular carcinoma (HCC) attributable to fatty liver disease is set to rise in the next 25 years, with obesity…

Last May, I turned 56. I feel OK about being in middle age, but I’ve long had fears about growing old. What I didn’t anticipate…

Enrollment is nearly complete in a Phase 2b clinical trial that’s testing Corcept Therapeutics‘ experimental oral therapy miricorilant in people with metabolic-associated steatohepatitis (MASH),…